R. De Caterina Lékařka. Autorka publikací z oboru.
De Caterina, R., 1954-
De Caterina, Raffaele, 1954-
De Caterina, R.
DeCaterina, R. 1954-
De Caterina, Raffaele
VIAF ID: 113268523 (Personal)
Permalink: http://viaf.org/viaf/113268523
Preferred Forms
- 200 _ | ‡a De Caterina ‡b Raffaele
- 100 1 _ ‡a De Caterina, R.
-
-
- 100 1 _ ‡a De Caterina, R., ‡d 1954-
-
-
-
-
- 100 1 _ ‡a De Caterina, Raffaele ‡d 1954-
-
- 100 1 _ ‡a DeCaterina, R. ‡d 1954-
- 100 0 _ ‡a R. De Caterina ‡c Lékařka. Autorka publikací z oboru.
4xx's: Alternate Name Forms (15)
Works
Title | Sources |
---|---|
Comparative Law and Economics | |
Fish Oil and Vascular Disease | |
Fourth universal definition of myocardial infarction (2018) | |
Kwas acetylosalicylowy w prewencji pierwotnej chorób sercowo-naczyniowych : dlaczego nie powinno się pochopnie rezygnowac ze stosowania tego leku = Aspirin for primary cardiovascular prevention : why the wonder drug should not br precipitously dismissed | |
n-3 fatty acids and vascular disease background and pathophysiology, hyperlipidaemia, renal diseases, ischaemic heart disease ; with 14 tables | |
[Pharmacogenetic algorithms for predicting the appropriate dose of vitamin K antagonists: are they still useful?] | |
[Practice guidelines 2007 for the treatment of arterial hypertension] | |
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction | |
Pre-Treatment High-Sensitivity Troponin T for the Short-Term Prediction of Cardiac Outcomes in Patients on Immune Checkpoint Inhibitors | |
Predictors of strut coverage of drug eluting stent implantation in diabetic patients- Is only on-clopidogrel platelet reactivity enough? Reply | |
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs | |
PrevenTion of contrast-inducEd nephropAThy with urinE alkalinization: the TEATE study design | |
Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). | |
Principles of nutrigenetics and nutrigenomics : fundamentals of individualized nutrition | |
Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy | |
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score | |
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis | |
Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. | |
Prominent role of NF-kappaB in the induction of endothelial activation by endogenous nitric oxide inhibition | |
Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells | |
Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia | |
Proton pump inhibitors and clopidogrel: an association to avoid? | |
Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion. | |
QT dispersion and myonecrosis after stent percutaneous coronary intervention | |
Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. | |
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions | |
Recent developments in cardiovascular stem cells. | |
Recommendations for the management of patients after heart valve surgery | |
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound stu | |
Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship | |
Regulation of endothelial function in coronary microcirculation by HMG-CoA reductase drugs | |
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study). | |
Relevance of new drug discovery to reduce NF-κB activation in cardiovascular disease | |
Right heart-pulmonary circulation unit and cardiac resynchronization therapy. | |
Risk of stroke after transcatheter aortic valve implant: the role of the new oral anticoagulants | |
Role and importance of ultrasound lung comets in acute cardiac care | |
Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. | |
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly | |
Scoring atherosclerosis in the search of evidence-based personalized medicine | |
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study | |
Should We Continue Assessing Glomerular Filtration Rate with the Cockroft-Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem | |
Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism | |
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. | |
Sodium-hydrogen exchangers (NHE) in human cardiovascular diseases: interfering strategies and their therapeutic applications. | |
ST-segment/heart rate hysteresis improves the exercise testing accuracy for coronary artery detection in asymptomatic patients with severe aortic stenosis | |
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. | |
Stem cells and growth factor delivery systems for cardiovascular disease. | |
Stroke prevention in atrial fibrillation: current status and near-future directions | |
Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease | |
Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe. | |
Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection | |
Targeting thrombin long-term after an acute coronary syndrome: Opportunities and challenges | |
Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes. | |
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies | |
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies | |
Towards a tailored use of eluted drugs for percutaneous coronary interventions | |
Transcriptome-based identification of new anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions [corrected]. | |
Transplantation of mesenchymal cells improves peripheral limb ischemia in diabetic rats. | |
Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair | |
Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study. | |
Understanding the complexity of abciximab-related thrombocytopenia | |
[Unusual case of interventricular septal defect in tertiary syphilis] | |
Up-titration of allopurinol in patients with gout | |
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study | |
The usefulness of the anaerobic threshold in the assessment and prognostic evaluation of the patient with dyspnea. | |
[Usefulness, timing and modality of ECG stress testing after myocardial revascularization] | |
The value of imaging in subclinical coronary artery disease | |
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. | |
Vasculoprotective potential of olive oil components. | |
VEGF receptor switching in heart development and disease | |
Vitamin K antagonists and osteoporotic fractures: insights from comparisons with the NOACs | |
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease | |
Von Willebrand factor, ADAMTS13, and coronary microvascular obstruction: beautiful hypotheses, ugly facts | |
What is 'valvular' atrial fibrillation? A reappraisal | |
Where are clots in atrial fibrillation? Did we have the wrong assumptions over the last decades? |